Tipifarnib in Treating Patients With Recurrent Bladder Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 2002

Primary Completion Date

March 31, 2006

Conditions
Bladder Cancer
Interventions
DRUG

tipifarnib

Trial Locations (7)

60640

Louis A. Weiss Memorial Hospital, Chicago

60637-1470

University of Chicago Cancer Research Center, Chicago

V5Z 355

Vancouver General Hospital, Vancouver

L8N 4A6

St. Joseph's Hospital, Hamilton

N6A 4L6

London Regional Cancer Program at London Health Sciences Centre, London

M4N 3M5

Sunnybrook and Women's College Health Sciences Centre, North York

M5G 2M9

Princess Margaret Hospital, Toronto

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University Health Network, Toronto

OTHER

NCT00047216 - Tipifarnib in Treating Patients With Recurrent Bladder Cancer | Biotech Hunter | Biotech Hunter